|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
North Suffolk Mental Health Association |
| Information provided by: | North Suffolk Mental Health Association |
| ClinicalTrials.gov Identifier: | NCT00320697 |
Purpose
This study seeks to determine if continued treatment with bupropion and NRT can reduce the smoking relapse rate in patients with schizophrenia.
| Condition | Intervention | Phase |
|
Schizophrenia Schizoaffective Disorder Smokers |
Drug: bupropion Drug: transdermal nicotine patch Drug: short-acting nicotine replacement therapy |
Phase IV |
| MedlinePlus related topics: | Quitting Smoking Schizophrenia Smoking |
| Drug Information available for: | Bupropion hydrochloride Bupropion Nicotine polacrilex Nicotine tartrate |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
| Official Title: | A Trial of the Effects of Bupropion, Nicotine Replacement Therapy and CBT on Smoking Cessation and Smoking Relapse in Patients With Schizophrenia |
| Estimated Enrollment: | 300 |
| Study Start Date: | April 2006 |
![]() |
Show Detailed Description |
Eligibility
| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria
Contacts and Locations| Contact: Michael A. Dyer, BA | 617-912-7842 | mdyer2@partners.org |
| United States, Massachusetts | |||||
| Freedom Trail Clinic | Recruiting | ||||
| Boston, Massachusetts, United States, 02114 | |||||
| Contact: Michael A Dyer, BA 617-912-7842 mdyer2@partners.org | |||||
| North Suffolk Mental Health Association |
| Principal Investigator: | A Eden Evins, MD, MPH | North Suffolk Mental Health Association |
More Information
| Study ID Numbers: | CORRC 15-2005, HRC#2005-p-001950 |
| First Received: | April 28, 2006 |
| Last Updated: | September 29, 2008 |
| ClinicalTrials.gov Identifier: | NCT00320697 |
| Health Authority: | United States: Institutional Review Board |
|
|
|
|
|
|